science
Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease
By Info60 Australia Desk•Summary of reporting by News Hub - Medianet News Hub Archive•Sep 21, 2026•0 views•
Collaboration will generate human iPSC-derived brain cell models to investigate the effects of Evinco’s NK-EV platform on neuroinflammation Melbourne, Australia, 21 September 2026 – Evinco Therapeutics Pty Ltd (“Evinco” or “Company”) and the Australian Regenerative Medicine Institute (ARMI) today announced a research collaboration to advance a novel natural killer cell-derived extracellular vesicle (NK-EV) therapy for ... Continued
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Clearing the Path: Mars Launches Pet Adoption Resource Hub, as New Research Reveals What Holds Adopters Back | AAP
Australian Associated Press
Clearing the Path: Mars Launches Pet Adoption Resource Hub, as New Research Reveals What Holds Adopters Back
Australian Business Announcements
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment | AAP
Australian Associated Press
Is Zelira Therapeutics Ltd (ASX:ZLD) Gaining Attention as Cannabis Research and Product Development Shape the Session?
Kalkine Media
Astronomers produce the first complete picture of (gas) planet formation in action
The National Tribune